Gemina Laboratories Stock Buy Hold or Sell Recommendation

GLABF Stock  USD 0.55  0.01  1.79%   
Assuming the 90 days horizon and complete risk avoidance on your part, our recommendation regarding Gemina Laboratories is 'Strong Sell'. Macroaxis provides Gemina Laboratories buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GLABF positions.
  
Check out Gemina Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Gemina and provide practical buy, sell, or hold advice based on investors' constraints. Gemina Laboratories. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute Gemina Laboratories Buy or Sell Advice

The Gemina recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Gemina Laboratories. Macroaxis does not own or have any residual interests in Gemina Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Gemina Laboratories' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Gemina LaboratoriesBuy Gemina Laboratories
Strong Sell

Market Performance

GoodDetails

Volatility

Out of controlDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Above AverageDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Gemina Laboratories has a Mean Deviation of 3.64, Semi Deviation of 3.55, Standard Deviation of 6.96, Variance of 48.48, Downside Variance of 128.26 and Semi Variance of 12.62
We provide advice to complement the regular expert consensus on Gemina Laboratories. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Gemina Laboratories is not overpriced, please check out all Gemina Laboratories fundamentals, including its cash per share, book value per share, and the relationship between the net income and debt to equity . As Gemina Laboratories appears to be a penny stock we also urge to confirm its shares owned by insiders numbers.

Gemina Laboratories Trading Alerts and Improvement Suggestions

Gemina Laboratories is way too risky over 90 days horizon
Gemina Laboratories has some characteristics of a very speculative penny stock
Gemina Laboratories appears to be risky and price may revert if volatility continues
Gemina Laboratories has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 0.
Gemina Laboratories has accumulated about 2.95 M in cash with (3.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Roughly 56.0% of the company shares are held by company insiders

Gemina Laboratories Returns Distribution Density

The distribution of Gemina Laboratories' historical returns is an attempt to chart the uncertainty of Gemina Laboratories' future price movements. The chart of the probability distribution of Gemina Laboratories daily returns describes the distribution of returns around its average expected value. We use Gemina Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Gemina Laboratories returns is essential to provide solid investment advice for Gemina Laboratories.
Mean Return
1.10
Value At Risk
-5
Potential Upside
17.65
Standard Deviation
6.96
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Gemina Laboratories historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Gemina Laboratories Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Gemina Laboratories or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Gemina Laboratories' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Gemina otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.69
β
Beta against Dow Jones3.14
σ
Overall volatility
7.02
Ir
Information ratio 0.14

Gemina Laboratories Volatility Alert

Gemina Laboratories is showing large volatility of returns over the selected time horizon. Gemina Laboratories is a potential penny stock. Although Gemina Laboratories may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Gemina Laboratories. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Gemina instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Gemina Laboratories Fundamentals Vs Peers

Comparing Gemina Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Gemina Laboratories' direct or indirect competition across all of the common fundamentals between Gemina Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as Gemina Laboratories or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Gemina Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing Gemina Laboratories by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Gemina Laboratories to competition
FundamentalsGemina LaboratoriesPeer Average
Return On Equity-3.47-0.31
Return On Asset-1.48-0.14
Operating Margin979.18 %(5.51) %
Current Valuation17.22 M16.62 B
Shares Outstanding64.1 M571.82 M
Shares Owned By Insiders56.28 %10.09 %
Price To Book9.70 X9.51 X
Price To Sales5,790 X11.42 X
EBITDA(4.69 M)3.9 B
Net Income(4.73 M)570.98 M
Cash And Equivalents2.95 M2.7 B
Cash Per Share0.05 X5.01 X
Total Debt12.47 K5.32 B
Debt To Equity0.01 %48.70 %
Current Ratio2.50 X2.16 X
Book Value Per Share0.02 X1.93 K
Cash Flow From Operations(3.87 M)971.22 M
Earnings Per Share(0.08) X3.12 X
Number Of Employees518.84 K
Market Capitalization33.65 M19.03 B
Total Asset1.42 M29.47 B
Net Asset1.42 M

Gemina Laboratories Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Gemina . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Gemina Laboratories Buy or Sell Advice

When is the right time to buy or sell Gemina Laboratories? Buying financial instruments such as Gemina OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Gemina Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Gemina OTC Stock

Gemina Laboratories financial ratios help investors to determine whether Gemina OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gemina with respect to the benefits of owning Gemina Laboratories security.